Digital Health technology is a disruptive force in industry. It has the potential to be life-enhancing and life-extending. How does it impact life science industry? Who will lead the change?
A distinguished panel addressed these questions at an event in April 2016. It was hosted by Bristol-Myers Squibb, organized by Aleksandar Ruzicic, President of the INSEAD Healthcare Club of Switzerland, with support from regional partners Technologie Forum Zug and Canton Zug.
About 80 people participated in the event, including INSEAD alumni and guests from pharmaceutical and medtech companies, startups, insurance and technology companies. Read the report (pdf)